Virtu Financial LLC V Tv Therapeutics Inc. Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.72 - $1.01 $7,671 - $10,761	10,655 Added 47.11%	33,270 $27,000
Q4 2022 Feb 15, 2023	SELL	$0.66 - $1.02 $14,083 - $21,765	-21,339 Reduced 48.55%	22,615 $15,000
Q3 2022 Nov 07, 2022	BUY	$0.65 - $1.37 $3,506 - $7,391	5,395 Added 13.99%	43,954 $43,000
Q2 2022 Aug 09, 2022	BUY	$0.39 - $0.84 $15,038 - $32,389	38,559 New	38,559 $29,000
Q1 2022 May 17, 2022	SELL	$0.51 - $1.0 $48,188 - $94,488	-94,488 Closed	0 $0

Q4 2021 Feb 17, 2022	SELL	$0.95 - $1.69 $6,830 - $12,151	-7,190 Reduced 7.07%	94,488 $94,000
Q3 2021 Nov 12, 2021	BUY	$1.53 - $2.22 $155,567 - $225,725	101,678 New	101,678 $156,000
Q1 2021 May 19, 2021	SELL	$1.97 - $2.89 $74,251 - $108,926	-37,691 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.49 - $3.1 $56,159 - $116,842	37,691 New	37,691 $70,000
Q3 2020 Dec 11, 2020	SELL	$1.7 - $2.98 $262,510 - $460,165	-154,418 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$1.74 - $3.19 $268,687 - $492,593	154,418 New	154,418 $347,000
Q4 2019 Feb 04, 2020	SELL	$1.37 - $1.97 $104,861 - $150,785	-76,541 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$1.26 - $1.77 $59,684 - $83,843	47,369 Added 162.38%	76,541 $119,000
Q2 2019 Aug 13, 2019	BUY	$1.29 - $1.83 $37,631 - $53,384	29,172 New	29,172 $42,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.